Sesen Bio to Present at the H.C. Wainwright 21st Annual Global Investment Conference – Business Wire
Sesen Bio to Present at the H.C. Wainwright 21st Annual Global Investment Conference Business Wire
Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, tod.
Source: Investment New Feed